Skip to content
    Real-World Studies

    Longitudinal Symptom Trajectories in Glioma Survivorship

    Meng et alSupportive Care in Cancer

    Glioma and its associated antitumor therapies cause dynamically fluctuating symptoms that generate persistent physical and psychological impairments, compromising long-term quality of life. To evaluate the evolution of patients' symptom perceptions, coping mechanisms, and clinical demands over time, a longitudinal phenomenological study followed 12 glioma survivors across three distinct clinical timepoints: initial diagnosis (T1), 1 month post-surgery (T2), and 3 months post-surgery (T3). Semi-structured interview transcripts were analyzed using Colaizzi’s descriptive phenomenological method to extract essential themes of the long-term survivorship experience.
    The investigation identified four primary themes and associated categories: (1) self-perception and interpretation of the disease, (2) differentiated coping with symptoms, (3) practical dilemmas in symptom management, and (4) core needs in symptom management. The findings demonstrate that symptom trajectories in glioma survivorship are non-static and characterized by evolving clinical and psychological burdens. Consequently, the study emphasizes that standard episodic clinical evaluations are inadequate, underscoring the necessity for healthcare systems to implement structured, longitudinal, patient-centered intervention frameworks across the survivorship continuum to reduce symptom burden and improve quality of life.

    Key Takeaways

    • Phenomenological analysis across survivorship milestones identified four core symptom trajectory themes: disease self-perception and interpretation, differentiated coping with symptoms, practical dilemmas in symptom management, and core management needs.
    • Effective symptom modulation in glioma requires clinical care models to transition away from episodic management toward longitudinal, patient-centered intervention frameworks that address evolving physical and psychological burdens across the survivorship continuum.
    Read the original sourceSupportive Care in Cancer